Delivery Order SPE2DB22D3004-SPE2DB24FRY68
Award Date
9/25/24
Potential Completion Date
9/26/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at up to $1,741.50, is a firm fixed price delivery order for the pharmaceutical product Emgality 120 mg/ml penml. This award is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at...
This federal contract award is for the delivery of Emgality 120 mg/ml pen injectors to the Defense Logistics Agency (DLA). The $1,449.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 19, 2022. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products, including specialty medications, generic drugs, and medical devices, to various...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,739.03, is for the supply of Emgality 120 mg/ml pen injectors. It is a firm fixed-price contract with an ultimate completion date of April 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 120 mg/mL injectable medication. The $1,671.20 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award, valued at $1,737.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Emgality 120 mg/ml pens, a prescription medication, to support the DLA's medical supply requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,642.29 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml pen-injectors, a prescription medication used for the treatment of migraine. The award has an ultimate completion date of November 13, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,969.14 firm-fixed-price delivery order covers the supply of Emgality 120 mg/ml pen to DLA. The contract has an ultimate completion date of November 29, 2023 and was awarded on November 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Emgality 120 mg/ml pens, a prescription medication. The award, valued at $1,036.26, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
This federal contract award is for the delivery of Emgality 120 mg/mL pen-injectors to the Defense Logistics Agency (DLA). The $1,097.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of September 20, 2022 and was awarded on September 19, 2022. It does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Emgality 120 mg/mL injectable medication. The $2,658.47 firm fixed-price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the...